Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Burger, JA, Tedeschi, A, Barr, PM et al. (31 more authors) (2015) Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. New England Journal of Medicine, 373 (25). pp. 2425-2437. ISSN 0028-4793

Abstract

Metadata

Authors/Creators:
  • Burger, JA
  • Tedeschi, A
  • Barr, PM
  • Robak, T
  • Owen, C
  • Ghia, P
  • Bairey, O
  • Hillmen, P
  • Bartlett, NL
  • Li, J
  • Simpson, D
  • Grosicki, S
  • Devereux, S
  • McCarthy, H
  • Coutre, S
  • Quach, H
  • Gaidano, G
  • Maslyak, Z
  • Stevens, DA
  • Janssens, A
  • Offner, F
  • Mayer, J
  • O’Dwyer, M
  • Hellmann, A
  • Schuh, A
  • Siddiqi, T
  • Polliack, A
  • Tam, CS
  • Suri, D
  • Cheng, M
  • Clow, F
  • Styles, L
  • James, DF
  • Kipps, TJ
Copyright, Publisher and Additional Information: (c) 2015, Massachusetts Medical Society. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 17 December 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Jun 2017 15:37
Last Modified: 30 Jun 2017 15:37
Status: Published
Publisher: Massachusetts Medical Society
Identification Number: https://doi.org/10.1056/NEJMoa1509388

Share / Export

Statistics